Hepatitis A Vaccine, Purified Inactivated (VAQTA™)

Phase 3

Phase 3

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Competitive Landscape

0 competitors in Hepatitis A Virus Infection

Drug Information

Target Indication

Hepatitis A Virus Infection

Clinical Trial

Last updated: 1/15/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

MRK

MERCK

Related Pipeline

Diabetic Retinopathy

Osteoporosis

Cardiovascular Disease

Malignant Neoplasms of Male Genital Organs

HPV Positive Oropharyngeal Squamous Cell Carcinoma

Get Catalyst Alerts

Receive weekly digests of upcoming catalysts